Drooping eyelids can be difficult to deal with. They tend to hinder proper vision and make one feel older than they actually are. Thankfully, there are now cosmetic interventions that can address these issues.
Upneeq is an innovative topical treatment that can successfully rejuvenate the upper face region.
Upneeq is a non-invasive, FDA-approved treatment that is designed to treat eyelid ptosis. This technique forgoes surgery and dermal fillers, using instead a simple eye drop formula that resolves the issue. This method enables patients to achieve a more attractive smile and upper-facial appearance without the risk or downtime associated with eyelid surgery. In some cases, patients notice that their faces look more youthful just minutes after the eyedrops are applied.
Whether a patient’s drooping eyelids are the result of the natural aging process or a genetic trait that was passed down to them, they can be a source of great frustration for patients.
Eyelid ptosis is also a potential condition for patients who have undergone surgery for cataracts, use contact lenses on a regular basis, or are afflicted by certain health conditions.
Overall, Upneeq eye drops are considered to be an ideal treatment for patients who want to avoid the potential risks, pain, scars, and downtime that are often associated with surgery.
Upneeq was designed specifically for the treatment of acquired blepharoptosis, a condition in which the upper lids become weaker and start sagging. Upneeq is defined as an alpha-adrenergic agonist that is formulated with oxymetazoline hydrochloride ophthalmic solution, 0.1%. Oxymetazoline. Its primary ingredient works by causing the Muller’s muscle in the upper eyelid to contract, which induces a sizable lift. According to recent data, the application of these eyedrops leads to a lift of 1 to 3 millimeters, on average.
As with any cosmetic procedure, the first step is for patients to meet with the practitioner and discuss all of their goals. During this time, the doctor can carry out a proper assessment of the patient’s condition and curate a treatment plan that will best address their issues. This is definitely the best course of action when preparing for Upneeq.
It is vital that the liquid be totally clear before being applied. Patients who wear contact lenses need to remove them prior to the treatment. They can then be put back in 15 minutes after the procedure is finished.
The Upneeq application process is remarkably similar to the application of standard eye drops. The patient must lean their head back and make sure to keep their eyes wide open. The eyedropper must be held directly above the patient’s eye before releasing the drop, which must be done one at a time. After all the drops have been applied, the patient has a chance to close their eyes and let the formula be absorbed. Patients must wait at least one minute before touching their eyes. It is also incredibly important that the vial never makes contact with the eyes, as this can cause contamination.
The results are usually noticeable in a matter of minutes to hours.
There is no downtime with Upneeq. That said, it is recommended that patients wait at least 15 minutes after applying the eyedrops before getting behind the wheel of a car.
For years Dr. Sean Paul has been providing the greater Austin area with some of the best cosmetic and surgical care available. Founder of Austin Face & Body, Dr. Paul has become a highly-revered name in his field and has done business around the world. With board certification from the American Board of Ophthalmology, he specializes in both cosmetic and reconstructive eyelid and facial plastic surgery.
Beyond his extensive educational background and expertise, Dr. Paul is known for establishing strong connections with his patients. He works tirelessly to ensure that each and every one of them get the attention that they deserve and leave his office looking and feeling their best.
Reach out to us today to schedule a private consultation.
Copyright Austin Oculofacial Plastics. All Rights Reserved. Designed & Developed by Studio III
